To amend sections 3902.50 and 3902.70; to amend, for the purpose of adopting a new section number as indicated in parentheses, section 3902.72 (3902.75); and to enact new section 3902.72 of the Revised Code to prohibit drug manufacturers from taking certain actions regarding reimbursements made to 340B covered entities.
- Chamber
- House
- Introduced
- May 14, 2025
- Last action
- May 21, 2025 — Referred to committee
- Session
- 136
- Momentum
- 29 · Low